FSANZ approves Nestlé infant formula L-histidine level amendment
Food Standards Australia New Zealand (FSANZ) has provisionally approved an application by Nestlé to reduce the minimum requirement for L-histidine in infant formula products
Archives for November 8, 2012
Glanbia expands heat process for flaxseed safety
Glanbia Nutritionals has expanded its heat treatment process for use with its milled and cracked flaxseed range.
DSM buys Fortitech for €495m; “We are done for awhile”
Rampant nutrition business acquirer, Royal DSM, has splashed the cash for the ninth time in two years – this time to the tune of €495m ($634m) on US-based multinational nutrient blending giant, Fortitech (€212m/$270m annual turnover).
Probiotics may ease eczema for children: RCT data
Daily supplements of the probiotic Lactobacillus plantarum CJLP133 may improve eczema in children, says a new study from South Korea.
Creating a healthier Europe: EU project calls for better data on policy impact
Policy makers must collect more high quality data to evaluating the effectiveness of current healthy eating campaigns if future strategies are to be successful, say researchers behind the EATWELL project.
Open innovation in action: Tate and Lyle creates ventures fund
Tate & Lyle will pump up to £30m ($48m/€36.5m) over eight-years in a new venture capital fund that will invest in start-ups and expansion-stage companies in food sciences and enabling technologies.
Who has self-affirmed GRAS? New database addresses transparency concerns
A new database of self-affirmed GRAS (Generally Recognized as Safe) determinations has been launched to tackle concerns about a lack of transparency in the process.
Bioriginal to distribute Norwegian krill
Canadian lipid specialist Bioriginal has inked a deal with Olympic Seafood to distribute the Norwegian firm’s krill offerings.
New lawsuit targets Monster and its ‘dangerous and potentially lethal’ ingredient: EGCG
A lawsuit has been filed in Orange County, CA against Monster alleging that the company failed to warn against the dangers of a an extremely dangerous and potentially lethal ingredient epigallocatechin-3-gallate.